155 related articles for article (PubMed ID: 16400326)
41. Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas.
Beeter MC; Fazili T; Yeh YA
Cureus; 2023 Mar; 15(3):e35998. PubMed ID: 37041930
[TBL] [Abstract][Full Text] [Related]
42. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
Memeo L; Jhang J; Assaad AM; McKiernan JM; Murty VV; Hibshoosh H; Tong GX; Mansukhani MM
Am J Clin Pathol; 2007 Feb; 127(2):225-9. PubMed ID: 17210525
[TBL] [Abstract][Full Text] [Related]
44. Prostatic nephrogenic adenoma. Case report.
López Martín L; García Cardoso JV; Martín Vivas C; Gómez Muñoz J; Susaníbar Napurí LF; González Enguita C
Arch Esp Urol; 2011 Jun; 64(5):473-6. PubMed ID: 21705821
[TBL] [Abstract][Full Text] [Related]
45. Nephrogenic adenoma of the urinary bladder: a report of three cases and a review of the literature.
Kuzaka B; Pudełko P; Powała A; Górnicka B; Radziszewski P
Ann Transplant; 2014 Apr; 19():153-6. PubMed ID: 24686831
[TBL] [Abstract][Full Text] [Related]
46. Nephrogenic adenoma--a study with special reference to clinical presentation.
Peeker R; Aldenborg F; Fall M
Br J Urol; 1997 Oct; 80(4):539-42. PubMed ID: 9352688
[TBL] [Abstract][Full Text] [Related]
47. Nephrogenic adenoma.
McIntire TL; Soloway MS; Murphy WM
Urology; 1987 Mar; 29(3):237-41. PubMed ID: 3548004
[TBL] [Abstract][Full Text] [Related]
48. [Nephrogenic adenoma. Report of 4 new cases].
Congregado Ruiz B; Medina López R; Ruiz Mateos R; Campoy Martínez P; Pérez Pérez M; Soltero González A
Arch Esp Urol; 2000 May; 53(4):367-9. PubMed ID: 10900768
[TBL] [Abstract][Full Text] [Related]
49. Villous adenoma of urinary tract: a common tumor in an uncommon location.
Tamboli P; Ro JY
Adv Anat Pathol; 2000 Mar; 7(2):79-84. PubMed ID: 10721414
[TBL] [Abstract][Full Text] [Related]
50. Nephrogenic adenoma: report of a case and review of morphologic mimics.
Kunju LP
Arch Pathol Lab Med; 2010 Oct; 134(10):1455-9. PubMed ID: 20923300
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemistry in diagnostic surgical pathology of the prostate.
Hameed O; Humphrey PA
Semin Diagn Pathol; 2005 Feb; 22(1):88-104. PubMed ID: 16512601
[TBL] [Abstract][Full Text] [Related]
52. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
53. Expression of L1 Cell Adhesion Molecule (L1CAM), A Nephronal Principal Cell Marker, in Nephrogenic Adenoma.
Mannan R; Wang X; Mahapatra S; Wang S; Chinnaiyan AK; Skala SL; Zhang Y; McMurray LM; Zelenka-Wang S; Cao X; Sangoi AR; Dadhania V; Picken MM; Menon S; Ahmadie HA; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Mod Pathol; 2024 Jun; ():100540. PubMed ID: 38901674
[TBL] [Abstract][Full Text] [Related]
54. Expression of uroplakin II and GATA-3 in bladder cancer mimickers: caveats in the use of a limited panel to determine cell of origin in bladder lesions.
Leivo MZ; Tacha DE; Hansel DE
Hum Pathol; 2021 Jul; 113():28-33. PubMed ID: 33887302
[TBL] [Abstract][Full Text] [Related]
55. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.
Mazal PR; Stichenwirth M; Koller A; Blach S; Haitel A; Susani M
Mod Pathol; 2005 Apr; 18(4):535-40. PubMed ID: 15502805
[TBL] [Abstract][Full Text] [Related]
56. Nephrogenic adenoma of the urinary bladder--a case report and review of the literature.
Chosia M; Switała J; Domagała W
Pol J Pathol; 2002; 53(2):91-5. PubMed ID: 12140873
[TBL] [Abstract][Full Text] [Related]
57. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
[TBL] [Abstract][Full Text] [Related]
58. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
59. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
[TBL] [Abstract][Full Text] [Related]
60. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
